199 related articles for article (PubMed ID: 6253303)
1. Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females.
Christiansen C; Christensen MS; McNair P; Hagen C; Stocklund KE; Transbøl I
Eur J Clin Invest; 1980 Aug; 10(4):273-9. PubMed ID: 6253303
[TBL] [Abstract][Full Text] [Related]
2. Thiazide for the postponement of postmenopausal bone loss.
Transbøl I; Christensen MS; Jensen GF; Christiansen C; McNair P
Metabolism; 1982 Apr; 31(4):383-6. PubMed ID: 7078423
[TBL] [Abstract][Full Text] [Related]
3. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy.
Christiansen C; Christensen MS; Transbøl I
Lancet; 1981 Feb; 1(8218):459-61. PubMed ID: 6110089
[TBL] [Abstract][Full Text] [Related]
4. [Prevention of early post-menopausal bone mineral loss. Controlled 2-year study of 315 women].
Christiansen C; Christensen MS; Jensen J; McNair P; Hagen C; Stocklund KE; Transbøl I
Ugeskr Laeger; 1980 Oct; 142(44):2896-901. PubMed ID: 6255653
[No Abstract] [Full Text] [Related]
5. Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis.
Christiansen C; Christensen MS; Rødbro P; Hagen C; Transbøl I
Eur J Clin Invest; 1981 Aug; 11(4):305-9. PubMed ID: 6795047
[TBL] [Abstract][Full Text] [Related]
6. Thiazide diuretics and bone mineral content in postmenopausal women.
Adland-Davenport P; McKenzie MW; Notelovitz M; McKenzie LC; Pendergast JF
Am J Obstet Gynecol; 1985 Jul; 152(6 Pt 1):630-4. PubMed ID: 4025422
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of thiazide and estrogen upon bone mineral content and fracture prevalence.
Wasnich RD; Ross PD; Heilbrun LK; Vogel JM; Yano K; Benfante RJ
Obstet Gynecol; 1986 Apr; 67(4):457-62. PubMed ID: 3960416
[TBL] [Abstract][Full Text] [Related]
8. Total and local bone mineral during estrogen treatment: a placebo controlled trial.
Gotfredsen A; Riis BJ; Christiansen C
Bone Miner; 1986 Apr; 1(2):167-73. PubMed ID: 3334206
[TBL] [Abstract][Full Text] [Related]
9. Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial.
Reid IR; Ames RW; Orr-Walker BJ; Clearwater JM; Horne AM; Evans MC; Murray MA; McNeil AR; Gamble GD
Am J Med; 2000 Oct; 109(5):362-70. PubMed ID: 11020392
[TBL] [Abstract][Full Text] [Related]
10. Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium.
Jensen GF; Christiansen C; Transbøl I
Clin Endocrinol (Oxf); 1982 May; 16(5):515-24. PubMed ID: 7044620
[TBL] [Abstract][Full Text] [Related]
11. Clinical, biochemical and histological results of a double-blind trial with 1,25-dihydroxyvitamin D3, estradiol and placebo in post-menopausal osteoporosis.
Caniggia A; Delling G; Nuti R; Lorè F; Vattimo A
Acta Vitaminol Enzymol; 1984; 6(2):117-28. PubMed ID: 6388277
[TBL] [Abstract][Full Text] [Related]
12. Effects of thiazide- and loop-diuretics, alone or in combination, on calcitropic hormones and biochemical bone markers: a randomized controlled study.
Rejnmark L; Vestergaard P; Heickendorff L; Andreasen F; Mosekilde L
J Intern Med; 2001 Aug; 250(2):144-53. PubMed ID: 11489064
[TBL] [Abstract][Full Text] [Related]
13. Thiazides and seasonal bone change in healthy postmenopausal women.
Dawson-Hughes B; Harris S
Bone Miner; 1993 Apr; 21(1):41-51. PubMed ID: 8324419
[TBL] [Abstract][Full Text] [Related]
14. Factors in response to treatment of early postmenopausal bone loss.
Christiansen C; Mazess RB; Transbøl I; Jensen GF
Calcif Tissue Int; 1981; 33(6):575-81. PubMed ID: 6275967
[No Abstract] [Full Text] [Related]
15. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
Meier C; Woitge HW; Witte K; Lemmer B; Seibel MJ
J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008
[TBL] [Abstract][Full Text] [Related]
16. Metabolic effects of thiazide and 1,25-(OH)2 vitamin D in postmenopausal osteoporosis.
Sakhaee K; Zisman A; Poindexter JR; Zerwekh JE; Pak CY
Osteoporos Int; 1993 Jul; 3(4):209-14. PubMed ID: 8338977
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral content after renal transplantation. Placebo-controlled prospective study with 1,25-dihydroxy vitamin D3.
Neubauer E; Neubauer N; Ritz E; Dreikorn K; Krause KH
Klin Wochenschr; 1984 Jan; 62(2):93-6. PubMed ID: 6368958
[TBL] [Abstract][Full Text] [Related]
18. Reversal of postmenopausal vertebral bone loss by oestrogen and progestogen: a double blind placebo controlled study.
Munk-Jensen N; Pors Nielsen S; Obel EB; Bonne Eriksen P
Br Med J (Clin Res Ed); 1988 Apr; 296(6630):1150-2. PubMed ID: 3132244
[TBL] [Abstract][Full Text] [Related]
19. Body size, estrogen use and thiazide diuretic use affect 5-year radial bone loss in postmenopausal women.
Sowers MR; Clark MK; Jannausch ML; Wallace RB
Osteoporos Int; 1993 Dec; 3(6):314-21. PubMed ID: 8292842
[TBL] [Abstract][Full Text] [Related]
20. Does 24R,25(OH)2-vitamin D3 prevent postmenopausal bone loss?
Riis BJ; Thomsen K; Christiansen C
Calcif Tissue Int; 1986 Sep; 39(3):128-32. PubMed ID: 3093022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
